In trading on Thursday, shares of US Bancorp's Series B Non-Cumulative Perpetual Preferred Stock (Symbol: USB.PRH) were yielding above the 8.5% mark based on its quarterly dividend (annualized to $1.5767), with shares changing hands as low as $18.50 on the day. This compares
(RTTNews) - Kratos Defense & Security Solutions, Inc. (KTOS) on Thursday announced that it was awarded a $16 million Foreign Military Sales award issued by the United States Army's Program Executive Office (PEO) Aviation Utility Project Office for Kratos' UH-60M aviation trainers
In a world of perfect blockchain-based fintech and Web3 applications, Ethereum (CRYPTO: ETH) wouldn't need any help. The leading smart-contracts platform would be able to handle millions or even billions of transactions every day without skipping a beat. But in the real world, Et
Developers in the U.S. offshore wind industry will likely cancel some power sales contracts in New York after the state last week denied passing on more of the costs to consumers, but major projects off Massachusetts and Rhode Island are set to start up later this year.
Below is Validea's guru fundamental report for NXP SEMICONDUCTORS NV (NXPI). Of the 22 guru strategies we follow, NXPI rates highest using our Twin Momentum Investor model based on the published strategy of Dashan Huang. This momentum model looks for a combination of fundamental
Below is Validea's guru fundamental report for DEXCOM, INC. (DXCM). Of the 22 guru strategies we follow, DXCM rates highest using our P/B Growth Investor model based on the published strategy of Partha Mohanram. This growth model looks for low book-to-market stocks that exhibit
Below is Validea's guru fundamental report for WORKDAY INC (WDAY). Of the 22 guru strategies we follow, WDAY rates highest using our P/B Growth Investor model based on the published strategy of Partha Mohanram. This growth model looks for low book-to-market stocks that exhibit c
Below is Validea's guru fundamental report for PROGRESSIVE CORP (PGR). Of the 22 guru strategies we follow, PGR rates highest using our Growth Investor model based on the published strategy of Martin Zweig. This strategy looks for growth stocks with persistent accelerating earni
Below is Validea's guru fundamental report for STRYKER CORP (SYK). Of the 22 guru strategies we follow, SYK rates highest using our Multi-Factor Investor model based on the published strategy of Pim van Vliet. This multi-factor model seeks low volatility stocks that also have st
Below is Validea's guru fundamental report for CARVANA CO (CVNA). Of the 22 guru strategies we follow, CVNA rates highest using our Small-Cap Growth Investor model based on the published strategy of Motley Fool. This strategy looks for small cap growth stocks with solid fundamen
Below is Validea's guru fundamental report for SYNOPSYS INC (SNPS). Of the 22 guru strategies we follow, SNPS rates highest using our Twin Momentum Investor model based on the published strategy of Dashan Huang. This momentum model looks for a combination of fundamental momentum
(RTTNews) - Kia America said its 2024 EV6 is anticipated to go on sale in Fall 2023. Excluding $1,325 destination fee, the all-electric 2024 EV6 is priced at, MSRP: EV6 Light RWD: $42,600; EV6 Light Long Range RWD: $45,950; EV6 Light e-AWD: $49,850; EV6 Wind RWD: $48,700; EV6 Win
(RTTNews) - Biotechnology company Beam Therapeutics Inc. (BEAM) announced Thursday their portfolio priorities and plans to streamline its business operations to support potential near-term value drivers and long-term growth.
(RTTNews) - Chesapeake Utilities Corp. (CPK) announced on Thursday that its unit Eastern Shore Natural Gas Company plans to invest $80 million in the Worcester Resiliency Upgrade project, a liquefied natural gas storage facility in Maryland.
The stock market hasn't been too kind to Devon Energy (NYSE: DVN) this year, with the stock down over 12% year to date (YTD) (as of Oct. 18). Some would point to Devon Energy's performance this year as just another example of the energy sector's cyclical nature, but I'd point to
Health care stocks were declining premarket Thursday, with the Health Care Select Sector SPDR Fund (XLV) down 0.2% and the iShares Biotechnology ETF (IBB) marginally lower recently.
Bristol Myers Squibb (NYSE: BMY) is one of the best-known healthcare companies in the world. Its roots go back to the 1800s, and it has continually evolved and gotten bigger over the years. Today, it generates more than $45 billion in annual revenue with its medications serving m
Investors who want to turn $100,000 into $1 million will need patience. Even if we assume a window of 30 years to 10x your portfolio, that would require an annualized growth rate of 8.33%. Still, plenty of growth stocks have beaten that result over the past 30 years.